Dose intensity in cancer chemotherapy
1990

Dose Intensity in Cancer Chemotherapy

Editorial Evidence: moderate

Author Information

Author(s): D.J. Dodwell, H. Gurney, N. Thatcher

Primary Institution: CRC Dept of Medical Oncology, Christie Hospital

Hypothesis

Dose and dose intensity are important determinants of outcome in the treatment of human cancer with cytotoxic chemotherapy.

Conclusion

Higher dose intensity in chemotherapy may improve treatment outcomes for cancer patients.

Supporting Evidence

  • Studies show a steep dose-response curve for many anti-tumor agents.
  • Hryniuk and Bush found a linear relationship between response rate and average relative dose intensity.
  • High dose chemotherapy with autologous bone marrow rescue shows promise for solid tumors.

Takeaway

Giving more medicine can help people with cancer get better, but we need to be careful about how much we give.

Methodology

The review assesses evidence from retrospective and prospective studies on dose and dose intensity across various tumor types.

Potential Biases

Potential biases include the exclusion of certain patient groups and reliance on retrospective data.

Limitations

The analyses often rely on assumptions about drug equivalency and do not account for all variables affecting treatment outcomes.

Statistical Information

P-Value

p<0.0005

Confidence Interval

95% confidence intervals 65-96%

Statistical Significance

p<0.0005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication